Chemical Structure (Fosaprepitant For Injection Novaplus 1)
Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9428
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 0143-9428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Fosaprepitant For Injection Novaplus 2)
Description: Fosaprepitant is a lyophilized sterile injection for intravenous use. Each vial contains 150mg and needs to be discarded after single use. The product is manufactured by Hainan Pharmaceutical in China and distributed by Fikima Pharmaceuticals USA Inc. Dilution is required using novaplus.*
Logo (Fosaprepitant For Injection Novaplus 3)
This is a pharmaceutical product called Fosaprepitant for Injection, which comes in 150mg per vial. It is a sterile lyophilized powder meant for intravenous use only. It should be used with the proper dilution and reconstitution guidelines, and it should not be used with solutions containing divalent cations. The usual dosage should be prescribed by a medical professional, and the unused medicine should be disposed of. The brand name is Novaplus.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
